*Correspondence: Jun Xu, [email protected] This article was submitted to Endocrinology of Aging, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Studies are lacking on the safety and efficacy of GLP-agonists in decompensated NASH cirrhosis
Individual results may vary, and success depends on combining medication with lifestyle modifications including diet and exercise
May 16, 2025: More than 1,800 Active Lawsuits in Group Lawsuit for People Harmed by Ozempic As of May, there are 1,809 active lawsuits in the MDL representing people harmed by Ozempic and other GLP-1 drugs
The Department of Health and Human Services recommends at least 150 minutes of moderate intensity aerobic activity weekly, or 75 minutes of vigorous intensity activity